Cargando…
Development and Structural Modification of BACE1 Inhibitors
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder which usually occurs in the elderly. The accumulation of β-amyloid and the formation of neurofibrillary tangles are considered as the main pathogenies of AD. Research suggests that β-secretase 1 (BACE1) plays an important role in t...
Autores principales: | Gu, Ting, Wu, Wen-Yu, Dong, Ze-Xi, Yu, Shao-Peng, Sun, Ying, Zhong, Yue, Lu, Yu-Ting, Li, Nian-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155942/ https://www.ncbi.nlm.nih.gov/pubmed/28025519 http://dx.doi.org/10.3390/molecules22010004 |
Ejemplares similares
-
Developing BACE-1 inhibitors for FXS
por: Westmark, Cara J., et al.
Publicado: (2013) -
Post-Translational Modifications of BACE1 in Alzheimer's Disease
por: Wen, Wen, et al.
Publicado: (2022) -
Is It the Twilight of BACE1 Inhibitors?
por: Hrabinova, Martina, et al.
Publicado: (2021) -
Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties
por: Sun, De-Yang, et al.
Publicado: (2019) -
Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative
por: Gu, Ting, et al.
Publicado: (2017)